国药现代：获得盐酸氢吗啡酮注射液药品注册证书

Core Viewpoint - The announcement highlights that China National Pharmaceutical Group Modern (国药现代) has received approval from the National Medical Products Administration for the registration of hydromorphone hydrochloride injection, which is intended for patients requiring opioid analgesia [1] Company Summary - China National Pharmaceutical Group Modern's wholly-owned subsidiary, China National Pharmaceutical Group Industrial Co., Ltd., has successfully obtained the drug registration certificate for hydromorphone hydrochloride injection [1] - The approved drug is specifically designed for patients who need opioid medications for pain relief [1]